Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

No treatment fully prevents hair loss from chemotherapy yet.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Pregnant women often experience skin and hair changes, with over half getting stretch marks and pigment changes, and should be cautious with cosmetic procedures due to potential risks.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

Many patients find hair loss from chemotherapy very distressing, and while treatments like minoxidil and scalp cooling may help, there is no sure way to prevent it.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

The perception of excessive hair growth in women as abnormal is more influenced by cultural norms than by medical reasons.